Conclusions: in winter, tumornecrosis factor antagonists treatment does not increase the risk of upper respiratory tract infection in inflammatory arthritis patients.
结论：肿瘤坏死因子拮抗剂的应用未使冬季上呼吸道感染的风险增加，其治疗炎性关节炎的安全性较好。
2
Two groups were compared on the levels of serum tumornecrosis-a (TNF-a), interleukins-1 (IL-1) and IL-6 before and after the treatment.
观察两组治疗前后血清肿瘤坏死因子、白细胞介素- 1、白细胞介素- 6的水平。
3
Accurately and early differentiating tumor recurrence from radiation necrosis may directly affect the treatment decision and prognosis of the patients.